About The Medical Condition Drug Evaluation, FDA Phase 4
Find the definition of the medical term Drug Evaluation, FDA Phase 4. Drug Evaluation, FDA Phase 4 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 4
| Drug Evaluation, FDA Phase 4 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 4?
Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Vitamin D-Resistant Rickets ‐ Familial disorder characterized by hypophosphatemia associated…
- Skin Diseases, Parasitic ‐ Skin diseases caused by arthropods, helminths, or…
- Outtakes (PT) ‐ Untitled raw motion picture and video footage which has not been…
- Oxidative Phosphorylations ‐ Electron transfer through the cytochrome system liberating free…
- Iodotyrosine ‐ A product from the iodination of tyrosine. In the biosynthesis…
- Beta-1 Subunit, Integrin ‐ Integrin beta-1 chains which are expresssed as heterodimers noncovalently…
- Cell Lineages ‐ The developmental history of cells as traced from the first division…
- Leukemias, Acute Myelocytic ‐ Progressive, malignant disease of the myeloid tissue in which…
- Antiaggregants, Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Rev-Responsive Elements, HIV ‐ DNA sequences that form the coding region for the viral envelope…